Intelligent Bio Solutions stock rises after announcing a manufacturing partnership targeting over 40% cost savings, major ...
CCC Intelligent Solutions Holdings Inc (NASDAQ:CCCS) is set to release its Q1 2025 earnings on May 6, 2025. The consensus estimate for Q1 2025 revenue is $249.85 million, and the earnings are expected ...
NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing ...
For the first quarter of 2025, CCC Intelligent Solutions expects revenue between $249 million and $250.5 million, surpassing analyst expectations of $246.3 million. The company's full-year 2025 ...
CHICAGO--(BUSINESS WIRE)--CCC Intelligent Solutions Holdings Inc. (CCC) (NASDAQ: CCCS), a leading cloud platform powering the P&C insurance economy, today announced that management will present at the ...
Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions ...
Intelligent Bio Solutions stock was down 14.06% in pre-market trading on Friday, following a 132.44% rally on the previous ...
Fintel reports that on January 6, 2026, Truist Securities initiated coverage of CCC Intelligent Solutions Holdings ...
The electricity industry is on the verge of an unprecedented boom, a new era, in which electrification, sustainability and carbon neutrality go hand in hand. Smart solutions and digital monitoring ...
CCC INTELLIGENT SOLUTIONS ($CCCS) posted quarterly earnings results on Tuesday, May 6th. The company reported earnings of $0.08 per share, missing estimates of $0.08 ...
Investing.com -- Intelligent Bio Solutions Inc. (NASDAQ:INBS) stock fell 21.3% in after-hours trading Wednesday following the company’s announcement of a $10 million private placement with two ...
This collaboration leverages the University of Cambridge’s deep expertise in fundamental wireless technology research, ...